Equites Radar

ALHC · Alignment Healthcare, Inc.

Healthcare PlansUnited StatesAnalyst view: Strong Buy

$18.67

-1.29% last session

End-of-day data · updated 2026-07-29

Mildly bearish1 bullish · 3 bearish technical signals
Consensus: Strong Buy (1.43 from 13 analysts)
To mean target: +33.5%

Market cap

$4B

Enterprise value

$3B

Trailing P/E

184.3

Forward P/E

25.5

Dividend yield

Beta

1.05

Avg volume

6M

Employees

2K

2D change

-1.29%

5D change

10D change

-10.53%

30D change

-20.77%

60D change

20.30%

MTD change

-23.24%

YTD change

-6.68%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.43
Covering analysts13
Mean price target$24.92
Low price target$16.00
Upside to mean target+33.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)39.1
50-day MA$19.33
200-day MA$19.31
Price vs 50-day MA-4.7%
Price vs 200-day MA-4.6%
MACD histogram-0.45
Volume vs 3-month avg1.0×
52w low $11.7652w high $24.56

Analyst sentiment over time — ALHC

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-05-26

Latest call per bank · past 12 months

Barclays

Equal-Weight

$16.00

-14.3% vs price
▼ cut from $19.00Maintains · 2026-05-26

UBS

Neutral

$22.00

+17.8% vs price
▲ raised from $21.00Maintains · 2026-05-01

JP Morgan

Overweight

$26.00

+39.3% vs price
▲ raised from $23.00Maintains · 2026-02-05

Goldman Sachs

Buy

$21.00

+12.5% vs price
▲ raised from $0.00Initiates · 2025-10-14

Recent rating actions

DateFirmActionRatingPrice target
2026-05-26BarclaysMaintainsEqual-Weight$19.00 $16.00
2026-05-01UBSMaintainsNeutral$21.00 $22.00
2026-05-01BarclaysMaintainsEqual-Weight$18.00 $19.00
2026-02-05JP MorganMaintainsOverweight$23.00 $26.00
2026-01-16TD CowenMaintainsBuy$18.50 $25.00
2026-01-14UBSMaintainsNeutral$18.00 $21.00
2026-01-06Piper SandlerMaintainsOverweight$20.00 $30.00
2025-12-17JP MorganMaintainsOverweight$20.00 $23.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 39 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 4.7% below the 50-day MA ($19.33).
  • Price vs 200-day MA: Trading 4.6% below the 200-day MA ($19.31).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.45) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($11.76) and high ($24.56).

ALHC Price Chart

Loading chart for ALHC

Fundamentals

Revenue (TTM)$4.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$1.00
Net debt / EBITDA-5.9
WACC11.0%
Revenue growth33.00%
Earnings growth

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

More in Healthcare Plans

Screen ALHC against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.